Travasol 680 mg (Proline SOLUTION) 680 MG

TRAVASOL 680 MG is an intravenous solution containing proline, designed to support nutritional needs. This product is manufactured by Baxter Corporation in Canada and is available in a 3000 mL pack size.

Strength

680 MG

Pack Size

3000

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

TRAVASOL 680 MG is primarily used as a nutritional supplement for patients who require intravenous nutrition. It provides essential amino acids, including proline, to support overall health and recovery. This solution is often used in clinical settings where oral nutrition is not feasible.

Side Effects

When administered intravenously, TRAVASOL 680 MG delivers amino acids directly into the bloodstream. This can help maintain nitrogen balance and support tissue repair. Patients may experience improved nutritional status and better overall well-being with regular use.

Precautions & Warnings

TRAVASOL 680 MG should be administered under medical supervision to ensure proper dosage and monitoring. It is important to follow healthcare provider instructions and monitor for any adverse reactions. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

TRAVASOL 680 MG may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, interactions with other intravenous solutions or nutrients should be considered.

Frequently Asked Questions

TRAVASOL 680 MG is used as a nutritional supplement to provide essential amino acids, including proline, for patients who require intravenous nutrition.

TRAVASOL 680 MG is administered intravenously, typically in a clinical setting under medical supervision.

Common effects include improved nutritional status and support for tissue repair due to the delivery of essential amino acids.

Yes, it should be administered under medical supervision, and patients should monitor for any adverse reactions.

Yes, it may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.